Bausch Health Companies Inc. (BHC): Price and Financial Metrics
BHC Price/Volume Stats
Current price | $9.41 | 52-week high | $10.15 |
Prev. close | $9.38 | 52-week low | $5.57 |
Day low | $9.41 | Volume | 1,402 |
Day high | $9.41 | Avg. volume | 2,325,630 |
50-day MA | $8.65 | Dividend yield | N/A |
200-day MA | $8.08 | Market Cap | 3.44B |
BHC Stock Price Chart Interactive Chart >
BHC POWR Grades
- Growth is the dimension where BHC ranks best; there it ranks ahead of 99.57% of US stocks.
- The strongest trend for BHC is in Growth, which has been heading up over the past 26 weeks.
- BHC ranks lowest in Momentum; there it ranks in the 6th percentile.
BHC Stock Summary
- BAUSCH HEALTH COMPANIES INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 2.14% of US listed stocks.
- Price to trailing twelve month operating cash flow for BHC is currently 2.55, higher than only 7.68% of US stocks with positive operating cash flow.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -31.09 for BAUSCH HEALTH COMPANIES INC; that's greater than it is for only 0.89% of US stocks.
- Stocks that are quantitatively similar to BHC, based on their financial statements, market capitalization, and price volatility, are RVNC, MRAI, CCLP, SOND, and AVAH.
- BHC's SEC filings can be seen here. And to visit BAUSCH HEALTH COMPANIES INC's official web site, go to www.bauschhealth.com.
BHC Valuation Summary
- BHC's price/sales ratio is 0.3; this is 92.86% lower than that of the median Healthcare stock.
- Over the past 243 months, BHC's price/sales ratio has gone down 4.3.
Below are key valuation metrics over time for BHC.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
BHC | 2023-12-29 | 0.3 | -2.5 | -3.0 | 45.3 |
BHC | 2023-12-28 | 0.3 | -2.5 | -3.0 | 45.3 |
BHC | 2023-12-27 | 0.3 | -2.4 | -2.9 | 45.1 |
BHC | 2023-12-26 | 0.3 | -2.4 | -2.9 | 45.0 |
BHC | 2023-12-22 | 0.3 | -2.3 | -2.8 | 44.9 |
BHC | 2023-12-21 | 0.3 | -2.3 | -2.8 | 44.9 |
BHC Growth Metrics
- Its year over year net cashflow from operations growth rate is now at -28.85%.
- Its year over year price growth rate is now at -66.36%.
- The 3 year revenue growth rate now stands at -0.9%.
The table below shows BHC's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 8,127 | -1,179 | 254 |
2022-06-30 | 8,192 | 648 | 43 |
2022-03-31 | 8,325 | 920 | -407 |
2021-12-31 | 8,434 | 1,426 | -948 |
2021-09-30 | 8,451 | 1,796 | -1,170 |
2021-06-30 | 8,478 | 1,488 | -1,287 |
BHC's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- BHC has a Quality Grade of C, ranking ahead of 53.93% of graded US stocks.
- BHC's asset turnover comes in at 0.276 -- ranking 162nd of 680 Pharmaceutical Products stocks.
- CCXI, NBY, and LLY are the stocks whose asset turnover ratios are most correlated with BHC.
The table below shows BHC's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.276 | 0.714 | -0.004 |
2021-03-31 | 0.259 | 0.714 | 0.006 |
2020-12-31 | 0.255 | 0.720 | 0.022 |
2020-09-30 | 0.250 | 0.721 | -0.017 |
2020-06-30 | 0.252 | 0.725 | -0.021 |
2020-03-31 | 0.265 | 0.729 | -0.011 |
BHC Price Target
For more insight on analysts targets of BHC, see our BHC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $36.08 | Average Broker Recommendation | 1.62 (Moderate Buy) |
Bausch Health Companies Inc. (BHC) Company Bio
Bausch Health Cos. Inc. (formerly) Valeant Pharmaceuticals is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter products, and medical devices, including contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices. The company was founded in 1983 and is based in Laval, Canada.
Latest BHC News From Around the Web
Below are the latest news stories about BAUSCH HEALTH COMPANIES INC that investors may wish to consider to help them evaluate BHC as an investment opportunity.
Bausch Health (BHC) Ulcerative Colitis Drug Meets Primary GoalBausch's (BHC) amiselimod achieves the primary and key secondary endpoints, including clinical and endoscopic measures, in the double-blind period of a phase II study. |
Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative ColitisTrial Meets Both Primary and Key Secondary Endpoints LAVAL, QC / ACCESSWIRE / December 21, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") today announced positive topline results from the Company's Phase ... |
Are Medical Stocks Lagging Bausch Health (BHC) This Year?Here is how Bausch Health (BHC) and Connect Biopharma Holdings Limited Sponsored ADR (CNTB) have performed compared to their sector so far this year. |
DUOBRII(TM) Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec’s Public Drug PlanLAVAL, QC / ACCESSWIRE / December 18, 2023 / Bausch Health, Canada, part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), ("Bausch Health" or the "Company") today announced that DUOBRII™ (0.01% w/w halobetasol propionate and 0.045% w/w tazarotene), ... |
Implied Volatility Surging for On Bausch Health Companies (BHC) Stock OptionsInvestors need to pay close attention to Bausch Health Companies (BHC) stock based on the movements in the options market lately. |
BHC Price Returns
1-mo | 10.58% |
3-mo | 29.79% |
6-mo | 12.16% |
1-year | 23.65% |
3-year | -71.48% |
5-year | -63.05% |
YTD | 17.33% |
2023 | 27.71% |
2022 | -77.25% |
2021 | 32.74% |
2020 | -30.48% |
2019 | 61.99% |
Continue Researching BHC
Want to do more research on Bausch Health Companies Inc's stock and its price? Try the links below:Bausch Health Companies Inc (BHC) Stock Price | Nasdaq
Bausch Health Companies Inc (BHC) Stock Quote, History and News - Yahoo Finance
Bausch Health Companies Inc (BHC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...